Rare diseases
Investigational molecules
Locations
Back to Italy885 clinical trials in Prato, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on Long-term Safety and Effects of Efgartigimod PH20 SC for Adults with Bullous Pemphigoid
ItalyStudy on Imatinib and Chemotherapy Combination for Children with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
ItalyStudy of durvalumab, carboplatin and etoposide combination therapy for patients with metastatic large-cell neuroendocrine lung cancer who have not received previous treatment
ItalyStudy on Reducing Asthma Medication with Tezepelumab in Patients Aged 12 to 80 with Severe Asthma
ItalyStudy on Guselkumab for Healing in Crohn's Disease Patients
ItalyStudy of AZD7798 compared to placebo in patients with moderate to severe Crohn's disease
ItalyStudy of Pacritinib for Patients with Severe Thrombocytopenia in Myelofibrosis Conditions
ItalyStudy on EYE103 and Ranibizumab for Patients with Diabetic Macular Edema
ItalyStudy on the Effectiveness and Safety of Remibrutinib for Teens with Chronic Spontaneous Urticaria Not Controlled by H1-Antihistamines
ItalyThe busiest research cities in the country
What the registry says about research in the country
Extensive clinical trials focusing on hormone receptor-positive and HER2-negative breast cancer treatments, including innovative therapies and maintenance strategies.
Multiple studies evaluating novel drug combinations and personalized treatment approaches for various breast cancer subtypes.
Innovative research in colorectal cancer and pancreatic cancer, exploring new treatment combinations and maintenance therapies.
Studies focus on improving survival rates and treatment effectiveness for advanced gastrointestinal cancers.
Research targeting ovarian cancer and related conditions, with emphasis on platinum-sensitive diseases and novel therapeutic combinations.
Trials exploring new approaches for treating various types of gynecologic cancers with innovative drug combinations.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
